Skip to content

Clinical trials

Completed Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Status: Completed Clear all

667 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20016
200210
200313
200415
200522
200633
200738
200841
200932
201039
201128
201233
201329
201439
201542
201621
201725
201829
201934
202027
202132
202222
202317
202411
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed667

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)44
Novartis Pharmaceuticals37
Bayer20
Notal Vision Ltd.20
Allergan12
Alcon Research11
Genentech, Inc.10
GlaxoSmithKline9
Pfizer9
Association for Innovation and Biomedical Research on Light and Image8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration667
Choroidal Neovascularization86
Geographic Atrophy52
Diabetic Retinopathy43
Wet Macular Degeneration33
Retinal Vein Occlusion32
Retinal Diseases31
Vision Disorders29
Eye Diseases26
Macular Edema25

Trials

Showing 51 to 75 of 667. Each trial links to its page on Pharma Observatory.

567 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.